Allarity Therapeutics, Inc.

Develops personalized cancer drugs using a diagnostic platform to predict patient response.

ALLR | US

Overview

Corporate Details

ISIN(s):: US0167445008
LEI:
Country:: United States of America
Address:: 24 SCHOOL ST., 2ND FLOOR, 2108 BOSTON
Website:: https://allarity.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Allarity Therapeutics, Inc. is a clinical-stage precision medicine company focused on developing personalized cancer treatments. The company leverages its proprietary Drug Response Predictor (DRP®) technology, a diagnostic platform that analyzes tumor biology to predict a patient's response to specific therapies. This approach aims to refine patient selection and improve clinical outcomes for its pipeline of in-licensed oncology therapeutics. Allarity's lead clinical program is stenoparib, an orally available, dual-action small molecule inhibitor being advanced for patients with advanced recurrent ovarian cancer. The company's mission is to enhance patient outcomes through data-driven decision-making and personalized cancer care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Allarity Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Allarity Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Allarity Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
PHARMARESEARCH BIO Co., Ltd. A global biopharma firm creating regenerative medicine, pharmaceuticals, devices, and cosmetics.	South Korea	217950
PharmaResearch Co., Ltd. Develops regenerative medicine, devices & cosmetics using marine biotechnology.	South Korea	214450
PharmaSGP Holding SE Develops and markets leading natural OTC drugs for chronic conditions in the European market.	Germany	PSG
Pharmena S.A. Develops dietary supplements using its patented 1-MNA molecule to support healthy aging.	Poland	PHR
Pharmhold AD	Bulgaria	PHRM
Pharmicell Co.,Ltd. Biopharma firm in stem cell therapies, biochemicals, cell banking, and stem cell cosmetics.	South Korea	005690
Pharming Group N.V. Develops & commercializes protein & precision medicines for rare, life-threatening diseases.	Netherlands	PHARM
Pharming Group N.V. Develops and commercializes innovative protein therapies for rare, life-threatening diseases.	United States of America	PHAR
Pharmocann Global Ltd. Develops pharma-grade medical cannabis products like oils, ointments, tablets, and cosmetics.	Israel	PMCN-M
Pharvaris N.V. Developing oral therapies for rare angioedema to treat and prevent attacks.	United States of America	PHVS